ClinicalTrials.gov
public full text
Public Domain
KYSA-6: A Study of Anti-CD19 Chimeric Antigen Receptor T-Cell Therapy, in Patients With Generalized Myasthenia Gravis
A Study of the Anti-CD 19 Chimeric Antigen Receptor T Cell Therapy for Patients with Myasthenia Gravis
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Safety, Tolerability and Immunogenic Response of CV-MG01 in Patients With Myasthenia Gravis#846146
- FK506 Phase 3 Study: a Study for Steroid Non-resistant Myasthenia Gravis (MG) Patients#872770
- Efficacy and Safety Study of GB-0998 for Treatment of Generalized Myasthenia Gravis#1338176
- Clinical Study of Cizutamig in Generalized Myasthenia Gravis (gMG)#802702
- Holistic Assessment and Remote Digital MONitoring of mYasthenia Gravis Via MyoSense 360#860433
Record · ID 1420962
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive